Quality of life improvement results in the ALUMITES study, a randomised, controlled, multicenter phase IV study with house dust mites subcutaneous immunotherapy for allergic rhinitis. Six months interim analysis
Services
Services
Date issued
2013Journal title
Allergy
Type of content
Publicación de congreso
